Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics
Open Access
- 11 October 2018
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (3) , 546-555
Abstract
Combination chemotherapy has proved to be a favorable strategy to treat acute leukemia. However, the introduction of novel compounds remains challenging and is hindered by a lack of understanding their mechanistic interaction with established drugs. In the present study, we demonstrate a highly increased response of various acute leukemia cell lines, drug resistant cells and patient-derived xenograft cells by combining the recently introduced protein disulfide isomerase inhibitor PS89 with cytostatics. In leukemic cells, a proteomics based target fishing approach disclosed that PS89 impacts a whole network of endoplasmic reticulum homeostasis proteins. We elucidate that the strong apoptosis induction in combination with cytostatics is orchestrated by the PS89 target B-cell receptor-associated protein 31, which transduces apoptosis signals at the ER-mitochondria interface. Activation of caspase-8 and cleavage of BAP31 stimulate a pro-apoptotic crosstalk including endoplasmic reticulum calcium release and increased reactive oxygen species levels resulting in amplification of mitochondrial apoptosis. This study promotes PS89 as a novel chemosensitizing agent for acute leukemia treatment and uncovers that targeting the endoplasmic reticulum-mitochondria network of cell death is a promising approach in combination therapy.Keywords
This publication has 40 references indexed in Scilit:
- Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic LeukemiaCancer Cell, 2018
- Acute Myeloid LeukemiaNew England Journal of Medicine, 2015
- Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re‐sensitization by JNK inhibitionBritish Journal of Haematology, 2015
- Childhood and adolescent cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- Microtubules and resistance to tubulin-binding agentsNature Reviews Cancer, 2010
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009
- Mechanisms of drug combinations: interaction and network perspectivesNature Reviews Drug Discovery, 2009
- Acute lymphoblastic leukaemiaThe Lancet, 2008
- Multi-target therapeutics: when the whole is greater than the sum of the partsDrug Discovery Today, 2007